• Annexin V-PE Reagent: Precision Apoptosis Detection Workflow

  2026-06-19

  The Annexin V-PE Reagent streamlines early apoptosis detection with a rapid, one-step protocol adaptable to both flow cytometry and microscopy. By bridging recent structural insights from CD38 CAR-T research with robust assay design, this guide empowers researchers to maximize reliability, sensitivity, and throughput in apoptotic cell detection.

• Harnessing MK-0812: Advancing Monocyte Trafficking Inhibitio

  2026-06-18

  This article offers a strategic, evidence-driven perspective on leveraging MK-0812, a potent CCR2 antagonist, to dissect and inhibit monocyte trafficking in metabolic dysfunction-associated steatohepatitis (MASH). By integrating mechanistic insights from recent gut–liver axis research and TM6SF2 biology, we provide translational researchers with guidance for experimental design, protocol optimization, and future directions that extend beyond standard product documentation.

• Applied Cyanidin Chloride for Oxidative Stress and Skin Mode

  2026-06-18

  Cyanidin Chloride, a potent anthocyanin polyphenolic antioxidant from Bilberry, enables robust oxidative stress and inflammatory skin disease research with proven cell protectant and barrier-restorative effects. This guide translates recent reference breakthroughs and practical workflows into actionable protocols and troubleshooting strategies for advanced cell-based assays.

• Metronidazole as a Strategic Modulator of Drug Uptake Pathwa

  2026-06-17

  Explore Metronidazole’s dual role as an antibiotic and a selective OAT3 inhibitor, highlighting its impact on drug-drug interactions and experimental assay design. This article uniquely dissects transporter biology and assay optimization, setting it apart from existing resources.

• Lopinavir Identified as a MERS-CoV Inhibitor in Drug Repurpo

  2026-06-17

  de Wilde et al. performed a systematic screen of FDA-approved drugs and identified Lopinavir (ABT-378) as one of four small molecules that inhibit MERS-CoV replication in cell culture. This finding highlights the translational potential of repurposing HIV protease inhibitors for emerging coronavirus threats and provides a framework for rapid antiviral research.

• CCK-8s Drives ANP Secretion via NOX4–PGC-1α–PPAR Signaling i

  2026-06-16

  This study demonstrates that sulfated cholecystokinin octapeptide (CCK-8s) directly promotes atrial natriuretic peptide (ANP) secretion in isolated beating rat atria through activation of the NOX4–PGC-1α–PPARα/PPARγ signaling cascade. The work advances our understanding of cardiac hormone regulation and provides mechanistic insight into the roles of reactive oxygen species and nuclear receptor pathways in cardiovascular function.

• Intestinal TM6SF2 Regulates Gut–Liver Axis in MASH Pathogene

  2026-06-16

  The reference study uncovers a critical protective role for intestinal TM6SF2 in preventing metabolic dysfunction-associated steatohepatitis (MASH) by maintaining gut barrier integrity and modulating lipid and microbiota signaling. These findings offer mechanistic insight into the gut–liver axis and highlight new intervention strategies targeting lysophosphatidic acid signaling and immune cell recruitment.

• Puerarin Drives Osteogenic Differentiation via Nitric Oxide

  2026-06-15

  This study reveals that puerarin significantly enhances osteogenic differentiation of rat dental follicle cells by activating the nitric oxide pathway. The findings suggest a targeted mechanism relevant for periodontal tissue regeneration and highlight the utility of nitric oxide synthase inhibition as a mechanistic probe.

• Lenalidomide (CC-5013): Reliable Solutions for Myeloma Resea

  2026-06-15

  This article addresses common laboratory challenges in cell viability and immune modulation assays, focusing on how Lenalidomide (CC-5013) (SKU A4211) offers reproducible, data-backed solutions. Learn how to optimize protocols, interpret results, and select reliable sources for your multiple myeloma research workflows.

• Bedaquiline: Diarylquinoline Antibiotic for MDR Tuberculosis

  2026-06-14

  Bedaquiline is a diarylquinoline antibiotic that targets Mycobacterium tuberculosis F1FO-ATP synthase with high specificity, making it a key agent against multi-drug resistant strains. Its unique mechanism also disrupts cancer stem cell energy metabolism. This article details its atomic mechanisms, evidence benchmarks, and integration into research workflows.

• MK-1775: Wee1 Kinase Inhibitor for Precision Cell Cycle Stud

  2026-06-13

  MK-1775, a highly selective Wee1 kinase inhibitor, unlocks precise control of the G2 DNA damage checkpoint, enabling sensitization of p53-deficient tumor cells to chemotherapeutics. This guide distills validated workflows, troubleshooting insights, and data-driven optimizations for translational cancer research.

• Sunitinib: Multi-Targeted RTK Inhibitor for Advanced Cancer

  2026-06-12

  Sunitinib empowers laboratory teams to dissect and disrupt receptor tyrosine kinase signaling across diverse cancer models, offering finely tuned apoptosis induction and cell cycle arrest. This guide translates cutting-edge research and real-world workflows into actionable protocols—helping you maximize reproducibility and interpretability in tumor angiogenesis and cell viability assays.

• EP4 Deficiency in Macrophages Accelerates Atherosclerosis vi

  2026-06-12

  This study uncovers the mechanistic role of macrophage EP4 receptor deficiency in accelerating atherosclerosis through enhanced CD36-mediated lipid uptake and M1 polarization. The findings highlight EP4 as a key regulator of foam cell formation and inflammatory macrophage profiles, offering insights into potential therapeutic targets for cardiovascular disease.

• Moxidectin: Mechanistic Insights and Translational Potential

  2026-06-11

  Explore the multifaceted role of moxidectin as a macrocyclic lactone anthelmintic in both veterinary parasitic worm control and innovative antifungal synergy. This article offers advanced mechanistic analysis and practical guidance distinct from existing guides.

• Autophagy–Metastasis Signature Predicts CRC Prognosis and Im

  2026-06-11

  Bai et al. (2026) present a validated prognostic risk signature integrating autophagy and liver metastasis genes in colorectal cancer. Their multi-cohort bioinformatics and experimental study reveals that this signature predicts tumor immune microenvironment remodeling and resistance to immunotherapy, offering new translational targets for precision oncology.

15022 records 1/1002 page Next 12345 下5页 Last page